I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings.
TransCode is a pre-clinical biopharmaceutical company focused on the discovery, development, and commercialization of a pipeline of innovative microRNA-targeted therapeutics for treating metastatic cancer. The company has developed a targeted treatment of metastatic cancer that led to complete regression and lifetime remission after only 4-6 weeks of animal medicines. The Transcode Reg D offering is open to institutional investors to fund clinical trials to achieve Proof of Concept (POC) in humans. |
GolfSuites 1 is an emerging company focusing on developing golf-themed entertainment facilities that provide a fun, inclusive, and engaging environment. GolfSuites will offer top-of-the-line facilities to recreational golfers and coaching and holistic game improvement opportunities for more serious players. GolfSuites is accepting Regulation A+ investment reservations both from investors of all wealth levels. View our Offering Circular HERE. |
InSitu Biologics is an emerging biotech company focusing on the development of AnestaGel™, a long-acting non-opiate painkiller. |
Insitu has raised $2.57 million rapidly, and they have paused their Reg A+ to request the SEC to Qualify an increased share price for their offering. Their InSitu Reg A+ offering is currently accepting reservations. View our Offering Circular HERE. |
Open Labs |
Open Labs is disrupting the global skincare industry. Their sophisticated token-based ecosystem pays users for participating at all levels. |
Qmage is revolutionizing digital images. Each image becomes a standalone content store, including text, audio, video, URL, and shared in social media. |
Talketh provides low-cost internet call capabilities on slow (& fast) internet connections worldwide; 1.5 billion person market opportunity.
Note that Manhattan Street Capital receives payments from companies that raise capital on our website. See the Manhattan Street Capital terms. |